Self-Reported Mood Changes following 6 Months of Vagus Nerve Stimulation in Epilepsy Patients

Epilepsy and Behavior

Volumn 2, Issue 4, 2001, Pages 335-342

  Hoppe, Christian ^a   Helmstaedter, Christoph ^a   Scherrmann, Judith ^a   Elger, Christian E ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Epilepsy; Health related quality of life; Mood; Vagus nerve stimulation

Indexed keywords

EID: 0001214898     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1006/ebeh.2001.0194     Document Type: Article

References (31)

1. Cramer JA. Alternate endpoints for seizure measurement. Adv Neurol 1998;76:189-94.
2. Kanner AM, Palac S. Depression in epilepsy: a common but often unrecognized comorbid malady. Epilepsy Behav 2000;1: 37-51.
3. Jacoby A, Baker GA, Steen N, Potts P, Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: findings from a UK Community study. Epilepsia 1996;37:148-61.
4. Kohler C, Norstrand JA, Baltuch G, O'Connor MJ, Gur RE, French JA, Sperling MR. Depression in temporal lobe epilepsy before epilepsy surgery. Epilepsia 1999;40:336-40.
5. O'Donoghue MF, Goodridge DM, Redhead K, Sander JW, Duncan JS. Assessing the psychosocial consequences of epilepsy: a community-based study. Br J Gen Pract 1999;49:211-4.
6. Smith DF, Baker GA, Dewey M, Jacoby A, Chadwick DW. Seizure frequency, patient-perceived seizure severity and the psychosocial consequences of intractable epilepsy. Epilepsy Res 1991;9:231-41.
7. Okuma T, Kishimoto A, Inoue K, Matsumoto H, Ogura A. Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis: a preliminary report. Folia Psychiatr Neurol Jpn 1973;27:283-97.
8. Swann AC, Bowden CL, Morris D, et al. Depression during mania: treatment response to lithium or divalproex. Arch Gen Psychiatry 1997;54:37-42.
9. Trimble MR. New antiepileptic drugs and psychopathology. Neuropsychobiology 1998;38:149-51.
10. Suppes T, Brown ES, McElroy SL, et al. Lamotrigine for the treatment of bipolar disorder: a clinical case series. J Affect Disord 1999;53:95-8.
11. Harden CL, Lazar LM, Pick LH, et al. A beneficial effect on mood in partial epilepsy patients treated with gabapentin. Epilepsia 1999;40:1129-34.
12. Rush AJ, George MS, Sackheim HA, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: a multicenter study. J Biol Psychiatry 2000;47:276-86.
13. George MS, Sackheim HA, Rush JA, et al. Vagus nerve stimulation: a new tool for brain research and therapy. J Biol Psychiatry 2000;47:287-95.
14. Ben Menachem E, Manon Espaillat R, Ristanovic R, et al. Vagus nerve stimulation for treatment of partial seizures 1. A controlled study of effect on seizures (First International Vagus Nerve Stimulation Study Group). Epilepsia 1994;35:616-26.
15. Ramsay RE, Uthman BM, Augustinsson LE, et al. Vagus nerve stimulation for treatment of partial seizures. 2. Safety, side effects and tolerability (First International Vagus Nerve Stimulation Study Group). Epilepsia 1994;35:627-36.
16. George R, Salinsky M, Kuzniecky R, et al. Vagus nerve stimulation for treatment of partial seizures. 3. Long-term follow-up on first 67 patients exiting a controlled study (First International Vagus Nerve Stimulation Study Group). Epilepsia 1994; 35:637-43.
17. Handforth A, DeGiorgio CM, Schachter SC, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998;51:48-55.
18. Schachter SC, Saper CB. Vagus nerve stimulation. Epilepsia 1998;39:677-86.
19. Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 2000;42:203-10.
20. Harden, CL, Pulver MC, Ravdin LD, Nikolov B, Halper JP, Labar DR. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav 2000;1:93-9.
21. Zerssen D v, Koeller DM, Rey ER. Die Befindlichkeits-Skala B-S - ein einfaches Instrument zur Objektivierung von Befindlichkeits-Störungen insbesondere im Rahmen von Längsschnitt-Untersuchungen. Arzneimittelforschung 1970;20:915-8.
22. Beck AT. Depression: clinical, experimental, and theoretical aspects. New York: Hoeber, 1967.
23. Beck, AT, Steer, RA. Beck Depression Inventory manual. San Antonio: Psychological Corp., 1987.
24. Zung WWK. A rating instrument for anxiety disorders. Psychosomatics 1971;12:371-9.
25. Cramer JA, Perrine K, Devinsky O, Meador K. A brief questionnaire to screen for quality of life in epilepsy: the QOLIE-10. Epilepsia 1996;37:577-82.
26. Cramer JA, Arrigo C, Van Hammee G, Bromfield EB. Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam. Epilepsy Res 2000;41:29-38.
27. Helmstaedter C, Elger CE. Behavioral psychosocial scales for epilepsy. J Epilepsy 1994;7:13-23.
28. Faravelli C, Albanesi G, Poli EJ. Assessment of depression: a comparison of rating scales. Affect Disord 1986;11:245-53.
29. Birbeck GL, Kim S, Hays RD, Vickrey BG. Quality of life measures in epilepsy: how well can they detect change over time? Neurology 2000;54:1822-7.
30. ID. Behav Res Ther 1993;31:693-700.
31. Gottman JM, Rushe RH. The analysis of change: issues, fallacies, and new ideas. J Consult Clin Psychol 1993;61:907-10.